Ophthalmology CPT® Codes for 2026 + Modifiers
Jan 29, 2026
Ophthalmology billing spans routine eye exams, high-volume cataract surgery, retinal injections, laser procedures, and advanced diagnostic imaging—often across multiple sites of service. In 2026, reimbursement shifts, drug modifier enforcement, and new diagnostic code distinctions directly affect ophthalmology revenue. If your team is relying on last year’s coding assumptions, you may already be experiencing preventable denials or silent underpayments. Staying current on Ophthalmology CPT® codes and modifiers for 2026 is critical to protecting reimbursement and maintaining compliance.
Ophthalmology denials in 2026 aren’t random—they’re tied to predictable coding gaps.
We’re seeing increased denials tied to cataract reimbursement shifts, improper drug modifier use (-JW/-JZ), dark adaptation reporting errors, and facility vs. office payment confusion. These are fixable—but only if identified early.
Guarantee: We’ll identify your top ophthalmology denial drivers and give you a clear plan to correct them.
Get My Ophthalmology Denial Snapshot
Contact us to receive a Denial Snapshot showing exactly where reimbursement is breaking down—and how to fix it.
Major 2026 Update: Cataract Surgery Reimbursement (66984)
The most financially significant ophthalmology update in 2026 impacts the most commonly performed procedure in the specialty.
| CPT® Code | Description | 2026 Impact |
|---|---|---|
| 66984 | Cataract removal with intraocular lens (IOL) | Approximately 11% reduction in surgeon reimbursement in facility settings (ASC/Hospital) |
This reduction stems from CMS adjustments to indirect practice expense calculations. While the CPT® code itself has not changed, allowable reimbursement in facility environments has dropped meaningfully. In-office cataract cases may not experience the same percentage decrease, which makes site-of-service strategy more important than ever.
Revenue risk: Even small documentation gaps can result in downcoding, global period confusion, or payer scrutiny during post-payment audits.
An 11% reduction hurts even more when claims deny.
We’re seeing cataract claims delayed due to documentation gaps around medical necessity, surgical complexity, or global-period modifier use. Clean documentation is now more critical than ever.
Guarantee: We’ll identify where your cataract claims are losing revenue—and show you how to stop it.
Dark Adaptation Testing: 2026 Reporting Changes
2026 introduces a reporting split between diagnostic and screening dark adaptation testing, requiring more precise code selection.
| CPT® Code | Description | 2026 Note |
|---|---|---|
| 92284 | Diagnostic dark adaptation exam | Limited strictly to diagnostic testing (rod/cone sensitivity) |
| 92288 | Screening dark adaptation | New code; verify payer coverage |
Coverage caution: CMS has signaled potential non-valuation of 92288. Many payers may classify this as non-covered screening.
Billing 92288 incorrectly can trigger automatic denials.
Screening vs. diagnostic distinctions matter. If documentation doesn’t clearly support diagnostic intent, payers may reject or recoup payment.
Guarantee: We’ll review your diagnostic testing patterns and identify preventable denial triggers.
Evaluation, Eye Exams, and E/M Coding
| CPT® Code | Description |
|---|---|
| 92002 | New patient, intermediate eye exam |
| 92004 | New patient, comprehensive eye exam |
| 92012 | Established patient, intermediate eye exam |
| 92014 | Established patient, comprehensive eye exam |
| 99202–99205 | New patient E/M visits |
| 99212–99215 | Established patient E/M visits |
When E/M services occur on the same date as procedures such as intravitreal injections (67028), documentation must clearly support modifier -25.
E/M + procedure denials are rising in ophthalmology.
Modifier -25 misuse or weak documentation leads to bundling denials. We know the documentation language payers expect.
Guarantee: We’ll pinpoint why your E/M claims are denied—and what to fix.
Diagnostic Imaging & Testing Adjustments
| CPT® Code | Description |
|---|---|
| 92133 | OCT of optic nerve |
| 92134 | OCT of retina |
| 92083 | Visual field exam, extended |
| 92250 | Fundus photography |
2026 Efficiency Adjustment: CMS applied a -2.5% efficiency adjustment to many non-time-based CPT® codes. Diagnostic imaging may see modest reductions in RVUs.
“Silent” imaging reductions add up quickly.
Underpayments often go unnoticed unless actively monitored. We compare contracted allowables to expected RVUs to catch discrepancies.
Guarantee: We’ll identify underpayments hiding in your imaging claims.
Intravitreal Injections & Drug Modifier Enforcement
| CPT® Code | Description |
|---|---|
| 67028 | Intravitreal injection of medication |
| Modifier | Requirement |
|---|---|
| -JW | Report discarded drug amount |
| -JZ | Required when zero drug is discarded |
Claims for single-dose drugs without either modifier will reject under CMS edits.
Drug modifier mistakes trigger automatic rejections.
Missing -JW or -JZ leads to pre-payment denials. These are workflow failures—not complex coding problems.
Guarantee: We’ll identify injection-related denial patterns and eliminate them.
Commonly Used Ophthalmology Modifiers
| Modifier | Description |
|---|---|
| -25 | Significant, separately identifiable E/M |
| -50 | Bilateral procedure |
| -RT / -LT | Right or left eye |
| -24 | Unrelated E/M during global period |
| -57 | Decision for surgery |
| -79 | Unrelated procedure during global period |
ICD-10 Updates: Thyroid Orbitopathy Specificity
| ICD-10 Code | Description |
|---|---|
| H06.21 | Thyroid orbitopathy, right eye |
| H06.22 | Thyroid orbitopathy, left eye |
| H06.23 | Thyroid orbitopathy, bilateral |
2026 Watch List for Ophthalmology Teams
• Monitor 66984 reimbursement changes carefully.
• Confirm dark adaptation code selection (92284 vs 92288).
• Enforce -JW / -JZ compliance for injections.
• Audit E/M + procedure documentation for modifier -25 support.
Final Thoughts
Ophthalmology billing in 2026 reflects tighter drug modifier enforcement, significant cataract reimbursement shifts, expanded diagnostic distinctions, and greater scrutiny around E/M pairing. Proactive auditing and workflow alignment are essential to avoid preventable revenue loss.
If you’re still chasing ophthalmology denials, revenue is slipping through the cracks.
From cataract reimbursement reductions to drug modifier enforcement and diagnostic coding shifts, these changes require workflow-level solutions—not reactive fixes.
Guarantee: We’ll identify your top denial drivers and give you a concrete plan to correct them.
Trademark notice: CPT is a registered trademark of the American Medical Association.
For informational purposes only.
Contact us
“My husband and I have a small practice but we were looking for a medical billing company to consult us. We originally started with a local company with some satisfaction. However, our biggest problem was that they wanted us to change our existing EMR to software that they worked with. Quest National Services worked with our existing software so that we didn’t have to make expensive changes to our infrastructure. That saved us a lot of time and headache. I would definitely say that was one of the main reasons for why we switched and why we continue to work with Quest. As a small practice, they helped us without draining our resources.”
Adriana C.
